[HTML][HTML] Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives
Amyotrophic lateral sclerosis (ALS) is a rare deadly progressive neurological disease that
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …
Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives
S Najafi, P Najafi, NK Farkhad… - Iranian Journal of …, 2023 - search.proquest.com
Amyotrophic lateral sclerosis (ALS) is a rare deadly progressive neurological disease that
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …
[PDF][PDF] Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives
S Najafi, P Najafi, NK Farkhad, GH Torshizi, RA Darban… - Iran J Basic Med Sci, 2023 - sid.ir
Amyotrophic lateral sclerosis (ALS) is a rare, deadly, idiopathic neurological disease of the
human motor system mainly affecting the neurons responsible for controlling voluntary …
human motor system mainly affecting the neurons responsible for controlling voluntary …
[PDF][PDF] Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives
S Najafi, P Najafi, NK Farkhad, GH Torshizi… - Iran J Basic Med …, 2023 - researchgate.net
Amyotrophic lateral sclerosis (ALS) is a rare, deadly, idiopathic neurological disease of the
human motor system mainly affecting the neurons responsible for controlling voluntary …
human motor system mainly affecting the neurons responsible for controlling voluntary …
Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives.
S Najafi, P Najafi, NK Farkhad… - Iranian Journal of …, 2023 - search.ebscohost.com
Amyotrophic lateral sclerosis (ALS) is a rare deadly progressive neurological disease that
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …
Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives
S Najafi, P Najafi, N Kaffash Farkhad… - Iranian Journal of …, 2023 - ijbms.mums.ac.ir
Amyotrophic lateral sclerosis (ALS) is a rare deadly progressive neurological disease that
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …
Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives.
S Najafi, P Najafi, AR Boroumand… - Iranian Journal of …, 2023 - europepmc.org
Amyotrophic lateral sclerosis (ALS) is a rare deadly progressive neurological disease that
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …
Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives
S Najafi, P Najafi, N Kaffash Farkhad… - Iranian Journal of …, 2023 - journals.mums.ac.ir
Amyotrophic lateral sclerosis (ALS) is a rare deadly progressive neurological disease that
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …
[PDF][PDF] Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives
S Najafi, P Najafi, NK Farkhad… - Iran J Basic …, 2023 - pdfs.semanticscholar.org
Amyotrophic lateral sclerosis (ALS) is a rare, deadly, idiopathic neurological disease of the
human motor system mainly affecting the neurons responsible for controlling voluntary …
human motor system mainly affecting the neurons responsible for controlling voluntary …
Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives
S Najafi, P Najafi, NK Farkhad… - Iranian journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Amyotrophic lateral sclerosis (ALS) is a rare deadly progressive neurological disease that
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …
primarily affects the upper and lower motor neurons with an annual incidence rate of 0.6 to …